About Cysal

This innovative biotechnology company was founded in 2012 as a spin-out of the Institute for Molecular Microbiology and Biotechnology of the Westfälische Wilhelms-Universität in Münster. Cysal is active in the production of biopolymers, peptides, and especially dipeptides. Furthermore, Cysal specializes in developing biotechnology solutions in General.

Press releases

Info & Contact

Ahmed Sallam


Technologiehof Münster
Mendelstraße 11
48149 Münster

In portfolio

27. Jun 2012

Ulrike Kalapis

Investment Manager